NeurologyLive® Friday 5 — June 5, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more or watch now buttons for more details and information about each highlight.

1: Understanding Ocrelizumab’s Safe and Efficacious Profile in Preconceiving Women With MS: Kristen Krysko, MD

In a recent interview, Kristen Krysko, MD, a neurologist at St. Michael's Hospital, shared findings presented at CMSC 2026 from a large dataset on preconception ocrelizumab exposure among women with multiple sclerosis. [WATCH TIME: 5 minutes]

2: Factors Associated With Response to Cognitive Rehabilitation in Progressive MS: Cecilia Meza, MA

In a recent interview, Cecilia Meza, MA, a clinical research coordinator at SunnyBrook Health Sciences Centre, explained key factors of the computerized cognitive training program that contributed to cognitive improvement. [WATCH TIME: 3 minutes]

3: Improving Access to Cognitive Screening in Multiple Sclerosis Care: Elizabeth S. Gromisch, PhD, MSCS

In a recent interview, Elizabeth S. Gromisch, PhD, MSCS, a research neuropsychologist at Mount Sinai Rehabilitation Hospital, outlined hallmark patterns of cognitive impairment in multiple sclerosis at the 2026 CMSC Annual Meeting. [WATCH TIME: 6 minutes]

4: NeuroVoices: Rachel Kenney, PhD, on Integrating OCT Into the 2024 McDonald Criteria for Multiple Sclerosis

In our latest NeuroVoices Q&A, Rachel Kenney, PhD, assistant professor of neurology at NYU Grossman School of Medicine, discussed how optical coherence tomography can support the 2024 McDonald Criteria for multiple sclerosis at CMSC 2026.

5: Refining Myelitis Criteria to Reduce Misdiagnosis and Improve Care in Clinical Practice

In a recent Q&A, Kyle Blackburn, MD, a neurologist at UT Southwestern Medical Center, discussed new proposed updates to the diagnostic criteria and nosology for myelitis presented at the 2026 CMSC Annual Meeting.

Don’t have time to read or watch a full video interview? Click here to check out our shorts!